oronto, Ontario--(Newsfile Corp. - October 15, 2020) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the "Company" or "Datametrex") is pleased to announce that the Company has started to deploy in the market MiCovid Cam Temperature Scanners with COVID-19 testing customers from October 9, 2020. This product is a new AI thermal detector with facial recognition and non-contact temperature assessment device to identify and triage people who may have elevated temperatures.
Utilizing the latest AI chipset technology, MiCovid Cam offers immediate body temperature detection, a long sensor range, and a high level of accuracy. MiCovid Cam is fully integrated into Web Services API suite allowing third party and independent software developers to adopt body temperature data into their current and future software solutions. It is fast, non-contact, non-invasive and accurate so as to not delay or hamper the customer experience.
"As we potentially enter into a second wave of the COVID-19 there is a need to support the reopening of economies, and having another tool to support this with MiCovid Cam, which is a solution capable of fast tracking the safe return of customers to office buildings, restaurants, retail outlets, coffee shops, government offices, and educational institutions.", commented Marshall Gunter CEO of the Company.
The Company issued 2,500,000 stock options with an exercise price of $0.12 to a consultant pursuant to its stock option plan on October 7, 2020.The options will expire on October 1, 2023.
The Company also wishes to clarify certain statements included in its press release dated October 1, 2020 (the "CEO Update Release"). Certain statements included in the CEO Update Release constitute "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements contained in the CEO Update Release include statements with respect to the Company's intention regarding possibility of consolidating its common shares and the Company's anticipated profitability. The Company cautions readers that these forward-looking statements are not historical facts and may have involved estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. Specifically, forward-looking statements contained in the CEO Update Release were based on certain assumptions made by management of the Company, including with respect to the projected growth of the market for the Company's products, the Company's ability to meet customers' product demand, the projected financial performance of the Company, the Company's ability to obtain and maintain all necessary government approvals to operate its business and the absence of any unforeseen logistical delays in the Company's growth including those related to COVID-19. No assurance can be given that these expectations will prove to be correct. Undue reliance should not be placed on the forward-looking statements included in the CEO Update Release. The forward-looking statements included in the CEO Update Release were made as of the date of the CEO Update Release. The Company has undertaken no obligation to update or revise any forward-looking statement included in the CEO Update Release to reflect events or circumstances after the date on which such statements were made or to reflect the occurrence of unanticipated events, except as required by applicable securities laws.